UpStream Bio | SC 13G:超过5%持股股东披露文件-FMR LLC(11.822%),Abigail P. Johnson(11.822%)
UpStream Bio | 10-Q:季度报表
UpStream Bio | 8-K:Upstream Bio报告2024年第三季度财务业绩和近期业务亮点
UpStream Bio | SC 13D:超过5%持股股东披露文件
UpStream Bio | SC 13G:超过5%持股股东披露文件-BCLS Fund III Investments, LP(4.3%)
UpStream Bio | 4:持股变动声明-董事 Chimovits Erez
UpStream Bio | 4:持股变动声明-董事 ORBIMED ADVISORS LLC
UpStream Bio | SC 13D:超过5%持股股东披露文件-OrbiMed Advisors LLC(8.9%),OrbiMed Capital GP VIII LLC(8.9%)等
UpStream Bio | 4:持股变动声明-股东 AI Upstream LLC
UpStream Bio | SEC STAFF LETTER:其他
UpStream Bio | 4:持股变动声明-股东 Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
UpStream Bio | 4:持股变动声明-董事 Chimovits Erez
UpStream Bio | 4:持股变动声明-董事 Ruddy Marcella K.
UpStream Bio | 4:持股变动声明-董事 Fleming Harold Edward
UpStream Bio | 4:持股变动声明-董事 Beckman Daniella
UpStream Bio | 4:持股变动声明-董事 Ratcliffe Liam
UpStream Bio | 8-K:重大事件
UpStream Bio | S-8:员工福利计划证券登记
UpStream Bio | 424B4:募资说明书
UpStream Bio | EFFECT:其他
暂无数据
暂无数据